A Study of Absorption, Distribution, Metabolism and Excretion (ADME) of [14C]AZD4144

Trial Identifier:	D9440C00005
Sponsor:	AstraZeneca
Collaborator:	Quotient Sciences Limited
Start Date:	February 2026
Primary Completion Date:	May 2026
Study Completion Date:	May 2026

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
GB	Ruddington, GB, NG11 6JS

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.